Brief: Alliqua Biomedical Says Has Right To Terminate Agreement With Celularity, Provided Co Pays $1.45 Mln Fee
Jan 5 (Reuters) - Alliqua Biomedical Inc ALQA.O :
* ALLIQUA BIOMEDICAL SAYS HAS RIGHT TO TERMINATE ASSET
PURCHASE
AGREEMENT WITH CELULARITY, PROVIDED CO PAYS TERMINATION FEE OF
$1.45 MILLION - SEC FILING
* ALLIQUA BIOMEDICAL INC - CELULARITY MAY BE OBLIGATED TO
PAY A $3
MILLION REVERSE TERMINATION FEE IF ASSET PURCHASE AGREEMENT IS
TERMINATED BY CO
Source text for Eikon: (http://bit.ly/2CMZUYM)
Further company coverage: ALQA.O
((Bangalore.newsroom@thomsonreuters.com;))